Hyaluronic Acid Market Size, Share & Trends Analysis Report and
Segment Forecast, 2026 | Grand View Research, Inc
“The global hyaluronic acid market size was valued at USD 8.3 billion in 2018
and is projected to expand at a CAGR of 7.8% over the forecast period.”
The global Hyaluronic Acid Market size is expected to reach USD 15.25 billion by 2026 registering a CAGR of
7.8%, according to a new report by Grand View Research, Inc. Factors, such as increasing concern about toxic
chemicals, need for quick and evident results, and shorter recovery time are high impact rendering drivers of
this market. The market is witnessing rapid growth due to increasing adoption of aesthetic pr ocedures across
the globe.
Wide usage of hyaluronic acid surfaces in cardiovascular implants, such as stents and vascular grafts, for
improving the compatibility coupled with growing awareness about anti-aging products is driving the market. In
addition, increasing cases of obesity indicate a rising number of people suffering from orthopedic disorders,
which do not have any permanent cure and the treatments include pain-killers. However, hyaluronic acid-based
viscosupplements are expected to be a possible cure for joint pain. Orthovisc, approved in 2013, and Monovisc,
approved in 2016, by Anika Therapeutics, Inc. are among the popular viscosupplements.
Increasing popularity of cosmetic surgeries across the globe is also expected to boost the market growth. I n
2013, hyaluronan-based facial fillers received FDA approval, which is used in corrective measures, anti-aging
procedure, and filling fine lines. North America led the market in 2018. Presence of key companies, such as
Genzyme Corporation and Anika Therapeutics, in this region contributes to market growth. Increasing number
of anti-aging procedures performed and resultant demand for dermal fillers are expected to drive the regional
market further.
Follow Us:
To request a sample copy or view summary of this report, click the link below:
https://www.grandviewresearch.com/industry-analysis/hyaluronic-acid-market
Further key findings from the study suggest:

Rising cases of obesity resulting in increased number of cases of osteoarthritis and joint pain has
boosted the demand for hyaluronic acid injections as treatment

According to the studies, the number of people suffering from osteoarthritis is expected to grow from
53 million in 2012 to 78 million by 2040

Asia Pacific is anticipated to emerge as the fastest-growing regional market during the forecast period
due to growing geriatric population in China and Japan, which provides a large customer base for antiaging products and services

Some of the key companies in the global hyaluronic acid market are F. Hoffmann-La Roche Ltd.;
Seikagaku Corp.; Galderma S.A.; Sanofi (Genzyme); Anika Therapeutics, Inc.; Salix Pharmaceuticals;
Zimmer Holdings, Inc.; Allergan, Inc.; Ferring Pharmaceuticals, Inc.; and Smith & Nephew Plc
Grand View Research has segmented the global hyaluronic acid market on the basis of application and region:
Hyaluronic Acid Application Outlook (Revenue, USD Million, 2015 - 2026)

Dermal Fillers

Osteoarthritis
o
Single Injection
o
Three Injection
o
Five Injection

Ophthalmic

Vesicoureteral Reflux
Hyaluronic Acid Regional Outlook (Revenue, USD Million, 2015 - 2026)


North America
o
U.S.
o
Canada
Europe
o
Follow Us:
U.K.



o
Germany
o
France
o
Italy
o
Spain
Asia Pacific
o
India
o
China
o
Japan
Latin America
o
Brazil
o
Mexico
MEA
o
Follow Us:
South Africa
Table of Content of Hyaluronic Acid Market
Chapter 1 Methodology & Scope
1.1 Market Segmentation & Scope
1.1.1 Application
1.1.2 Regional
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details of Primary Research
1.3.5.1 Data for primary interviews in North America
1.3.5.2 Data for primary interviews in Europe
1.3.5.3 Data for primary interviews in Asia Pacific
1.3.5.4 Data for primary interviews in Latin America
1.3.5.5 Data for primary interviews in MEA
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.2 Volume Price Analysis (Model 2)
1.6.2.1 Approach 2: Volume Price Analysis
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective 1
1.10.2 Objective 2
Follow Us:
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.2.1 Application
2.2.2 Region
2.2.3 Competitive Insights
2.3 Market Outlook
Chapter 3 Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Related/Ancillary Market Outlook
3.2 Market segmentation
3.2.1 Market Driver Analysis
3.2.2 Market Restraint Analysis
3.3 Penetration & growth prospect mapping
3.4 Hyaluronic Acid Market Analysis Tools
3.4.1 PEST - SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
3.4.2 Industry Analysis - Porter’s
3.4.3 Major Delas And Strategic Analysis
3.4.3.1 Joint ventures, mergers and acquisition
3.4.3.2 Licensing & partnerships, technology collaborations
Chapter 4 Hyaluronic Acid Market: Application Estimates & Trend Analysis
4.1 Hyaluronic Acid market: Application Movement Analysis
4.2 Dermal Fillers
4.2.1 Dermal Fillers Market, 2015 - 2026 (USD Million)
4.3 Osteoarthritis
4.3.1 Osteoarthritis Market, 2015 - 2026 (USD Million)
4.3.2 Single Injection
4.3.2.1 Single injection market, 2015 - 2026 (USD Million)
4.3.3 Three Injection
4.3.3.1 Three injection market, 2015 - 2026 (USD Million)
Follow Us:
4.3.4 Five Injection
4.3.4.1 Five injection market, 2015 - 2026 (USD Million)
4.4 Ophthalmic
4.4.1 Ophthalmic Market, 2015 - 2026 (USD Million)
4.5 Vesicoureteral reflux
4.5.1 Vesicoureteral reflux Market, 2015 - 2026 (USD Million)
Chapter 5 Hyaluronic Acid Market: Regional Estimates & Trend Analysis
5.1 Hyaluronic Acid Market Share, by Region, 2018 & 2026
5.2 North America
5.2.1 North America Hyaluronic Acid Market, 2015 - 2026 (USD Million)
5.2.2 U.S
5.2.2.1 U.S hyaluronic acid market, 2015 - 2026 (USD Million)
5.2.3 Canada
5.2.3.1 Canada hyaluronic acid market, 2015 - 2026 (USD Million)
5.3 Europe
5.3.1 Europe Hyaluronic Acid Market, 2015 - 2026 (USD Million)
5.3.2 U.K.
5.3.2.1 U.K. hyaluronic acid market, 2015 - 2026 (USD Million)
5.3.3 Germany
5.3.3.1 Germany hyaluronic acid market, 2015 - 2026 (USD Million)
5.3.4 France
5.3.4.1 France hyaluronic acid market, 2015 - 2026 (USD Million)
5.3.5 Italy
5.3.5.1 Italy hyaluronic acid market, 2015 - 2026 (USD Million)
5.3.6 Spain
5.3.6.1 Spain hyaluronic acid market, 2015 - 2026 (USD Million)
5.4 Asia Pacific
5.4.1 Asia Pacific Hyaluronic Acid Market, 2015 - 2026 (USD Million)
5.4.2 India
5.4.2.1 India hyaluronic acid market, 2015 - 2026 (USD Million)
5.4.3 China
Follow Us:
5.4.3.1 China hyaluronic acid market, 2015 - 2026 (USD Million)
5.4.4 Japan
5.4.4.1 Japan hyaluronic acid market, 2015 - 2026 (USD Million)
5.5 Latin America
5.5.1 Latin America Hyaluronic Acid Market, 2015 - 2026 (USD Million)
5.5.2 Brazil
5.5.2.1 Brazil hyaluronic acid market, 2015 - 2026 (USD Million)
5.5.3 Mexico
5.5.3.1 Mexico hyaluronic acid market, 2015 - 2026 (USD Million)
5.6 MEA
5.5.1 MEA Hyaluronic Acid Market, 2015 - 2026 (USD Million)
5.5.2 South Africa
5.5.2.1 South Africa hyaluronic acid market, 2015 - 2026 (USD Million)
Chapter 6 Reimbursement Scenario
6.1 Reimbursement by Product
6.1.1 Gel-one
6.1.2 EUFLEXXA
6.1.3 Synvisc-One
6.1.4 Supartz
6.1.5 Hyalgan
6.1.6 Monovisc
6.1.7 Orthovisc
6.1.8 Juvéderm, Emervel, Restylane, Macrolane, Belotero, Filorga, Jalupro, Princess, Teosyal, Stylage,
Filorga and others
6.2 Reimbursement by Region
6.2.1 U.S.
6.2.2 Canada
6.2.3 China
6.2.4 Japan
6.2.5 India
6.2.6 Brazil
Follow Us:
6.2.7 South Africa
6.2.8 Europe
Chapter 7 Competitive Landscape
7.1 Recent Developments & Impact Analysis, by Key Market Participants
7.2 Strategy Framework
7.3 Vendor Landscape
7.3.1 List Of Key Distributors And Channel Partners
7.3.2 Strategy Mapping
7.3.2.1 Partnerships
7.3.2.2 Launch of new product
7.3.2.3 Merger & acquisition
7.3.2.4 Geographical expansion
7.3.2.5 Marketing & promotions
7.4 Company Market Position Analysis (Revenue, Geographic Presence, Product Portfolio, Strategic
Initiatives, Employee Strength)
7.5 Company Profiles
7.5.1 Allergan
7.5.1.1 Company overview
7.5.1.2 Financial performance
7.5.1.3 Product benchmarking
7.5.1.4 Strategic initiatives
7.5.1.5 SWOT analysis
7.5.2 Sanofi
7.5.2.1 Company overview
7.5.2.2 Financial performance
7.5.2.3 Product benchmarking
7.5.2.4 Strategic initiatives
7.5.2.5 SWOT analysis
7.5.3 Genzyme Corporation
7.5.3.1 Company overview
7.5.3.2 Financial performance
Follow Us:
7.5.3.3 Product benchmarking
7.5.3.4 Strategic initiatives
7.5.3.5 SWOT analysis
7.5.4 Anika Therapeutics, Inc.
7.5.4.1 Company overview
7.5.4.2 Financial performance
7.5.4.3 Product benchmarking
7.5.4.4 Strategic initiatives
7.5.4.5 SWOT analysis
7.5.5 Salix Pharmaceuticals, Inc.
7.5.5.1 Company overview
7.5.5.2 Financial performance
7.5.5.3 Product benchmarking
7.5.5.4 Strategic initiatives
7.5.5.5 SWOT analysis
7.5.6 Seikagaku Corporation
7.5.6.1 Company overview
7.5.6.2 Financial performance
7.5.6.3 Product benchmarking
7.5.6.4 Strategic initiatives
7.5.6.5 SWOT analysis
7.5.7 F. Hoffmann-La Roche AG
7.5.7.1 Company overview
7.5.7.2 Financial performance
7.5.7.3 Product benchmarking
7.5.8 Galderma S.A.
7.5.8.1 Company overview
7.5.8.2 Financial performance
7.5.8.3 Product benchmarking
7.5.8.4 Strategic initiatives
7.5.8.5 SWOT analysis
Follow Us:
7.5.9 Zimmer Biomet
7.5.9.1 Company overview
7.5.9.2 Financial performance
7.5.9.3 Product benchmarking
7.5.9.4 Strategic initiatives
7.5.9.5 SWOT analysis
7.5.10 Smith & Nephew Plc
7.5.10.1 Company overview
7.5.10.2 Financial performance
7.5.10.3 Product benchmarking
7.5.10.4 Strategic initiatives
7.5.10.5 SWOT analysis
7.5.11 Ferring B.V.
7.5.11.1 Company overview
7.5.11.2 Product benchmarking
7.5.11.3 Strategic initiatives
7.5.12 Lifecore Biomedical, LLC
7.5.12.1 Company overview
7.5.12.2 Financial performance
7.5.12.3 Product benchmarking
7.5.12.4 Strategic initiatives
7.5.12.5 SWOT analysis
7.5.13 HTL Biotechnology
7.5.13.1 Company overview
7.5.13.2 Product benchmarking
7.5.14 Shiseido
7.5.14.1 Company overview
7.5.14.2 Financial performance
7.5.14.3 Product benchmarking
7.5.14.4 Strategic initiatives
7.5.14.5 SWOT analysis
Follow Us:
7.5.15 Bloomage Freda Biopharm Co. Ltd.
7.5.15.1 Company overview
7.5.15.2 Product benchmarking
7.5.15.3 Strategic initiatives
7.5.16 LG Life Sciences Ltd
7.5.16.1 Company overview
7.5.16.2 Product benchmarking
7.5.16.3 Strategic initiatives
7.5.17 Maruha Nichiro, Inc.
7.5.17.1 Company overview
7.5.17.2 Financial performance
7.5.17.3 Product benchmarking
7.5.17.4 Strategic initiatives
7.5.17.5 SWOT analysis
7.5.18 Fluidigm Corporation
7.5.18.1 Company overview
7.5.18.2 Financial performance
7.5.18.3 Product benchmarking
7.5.18.4 Strategic initiatives
7.5.18.5 SWOT analysis
Chapter 8 Recommendations
Follow Us:
About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed business decisions, the company offers
market intelligence studies ensuring relevant and fact-based research across a range of industries including
technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: [email protected]
For More Information: https://www.grandviewresearch.com
Blog: https://healthcareforecastreport.blogspot.com/
Follow Us:

The global hyaluronic acid market size is expected to reach USD 15.25 billion by 2026 registering a CAGR of 7.8%, according to a new report by Grand View Research, Inc.